about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Fac­ing a crit­i­cal week, Pfiz­er con­fronts an un­spar­ing foe in Star­board

8 months ago
Pharma

J&J’s medtech slump con­tin­ues, im­prove­ments not ex­pect­ed un­til 2025

8 months ago
Pharma

J&J trims pipeline, in­clud­ing two mid-stage neu­ro­science stud­ies

8 months ago
R&D
Pharma

Sanofi lands on pri­vate eq­ui­ty firm CD&R as po­ten­tial buy­er of con­sumer health unit

8 months ago
Deals
Pharma

Sanofi dis­con­tin­ues De­nali-part­nered MS tri­al af­ter Phase 2 fail­ure

8 months ago
R&D

Ex­clu­sive: How an ac­ci­den­tal email tipped Pfiz­er off to an ac­tivist in­vestor’s plan

8 months ago
People
Pharma

Star­board launch­es first sal­vo in Pfiz­er fight, al­leg­ing ex-CEO, CFO were pres­sured to flip

8 months ago
R&D

For­mer Pfiz­er CEO and CFO flip on ac­tivist and say they now sup­port com­pa­ny

8 months ago
People
Pharma

Cov­er­ing obe­si­ty drugs could cost Medicare $35B by 2034, CBO says

8 months ago
FDA+

Pfiz­er's for­mer top ex­ec­u­tives pitched changes to board as part of ac­tivist's plan

8 months ago
People
Pharma

BAR­DA doles out $72M to Sanofi, GSK and CSL for bird flu vac­cine sup­ply

8 months ago
Pharma
FDA+

J&J dis­con­tin­ues mid-stage dengue study, cit­ing de­pri­or­i­ti­za­tion of com­mu­ni­ca­ble dis­ease work

8 months ago
R&D
Pharma

Ex­clu­sive: Re­lay Ther­a­peu­tics cuts an­oth­er 10% of com­pa­ny, cit­ing con­tin­ued stream­lin­ing ef­forts

8 months ago
People
R&D

Wave’s new cap­i­tal ex­tends cash run­way in­to 2027, CEO says

8 months ago
R&D

J&J and Bay­er to lay off al­most 300 staffers in New Jer­sey

8 months ago
People
Pharma

Cal­i­for­ni­a's Gavin New­som ve­toes bi­par­ti­san PBM re­form bill

8 months ago
Pharma

Kezar halts mid-stage lu­pus study af­ter four deaths

8 months ago
R&D

Rivus de­tails weight loss da­ta in heart fail­ure pa­tients and preps for new fundraise

8 months ago
Startups
R&D

FDA lifts hold on Bio­mea’s di­a­betes tri­als

9 months ago
Pharma
FDA+

Ex­clu­sive: J&J folds car­dio­vas­cu­lar and meta­bol­ic drug unit

9 months ago
R&D

Bal­ti­more sues Bio­gen, say­ing the com­pa­ny col­lud­ed with PBMs to min­i­mize gener­ic com­pe­ti­tion

9 months ago
Pharma
Law

SIGA fires for­mer NYC Covid ad­vi­sor af­ter se­cret record­ings de­tail pan­dem­ic-era par­ties

9 months ago
People
Pharma

Wave rides new Phase 2 DMD da­ta as it sets sights on ac­cel­er­at­ed ap­proval

9 months ago
R&D

Sanofi's Sar­clisa gets ap­proved as a first-line op­tion for some pa­tients new­ly di­ag­nosed with mul­ti­ple myelo­ma

9 months ago
Pharma
FDA+
First page Previous page 6789101112 Next page Last page
A service from the Financial Times